(ROSG) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
May 21, 2013
(Benzinga,
10/5/10)
Rosetta Genomics, Ltd. (NASDAQ: ROSG) today announced a corporate restructuring that is expected to result in a 32% reduction in the Company's monthly burn rate, thereby reducing annual operating expenses by approximately $4 million....(read more)
New Data Published Demonstrates Rosetta Genomics' miRview meso is a Highly Sensitive Test for Dif...
(Benzinga,
9/27/10)
Rosetta Genomics, Ltd. (NASDAQ: ROSG) announces that a peer reviewed article entitled "A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma" appears in the online version of "The Journal...(read more)
(AlphaNinja,
1/14/10)
E
xisting shareholders had a banner day yesterday, when Rosetta Genomics (ROSG) shares popped 67%, to cloase at 3.09 per share.
In its early stages, the company just added to its board of...(read more)
Rosetta Genomics (ROSG) Company Overview
There is no analysis for ROSG yet. But you can go to Wikinvest to help create one!
